It remains to be seen whether recent advances in continuous glucose monitoring and closed-loop insulin delivery will be effective for improving late gestation glucose control and reducing perinatal morbidity in type 1 diabetes pregnancy [24, 25]. The gene discussed is INS; the disease is type 1 diabetes mellitus.